Tell Us What Happened
Please contact us if you have questions about our company, our products, or general enquiries.
Please use the form.
Zebrafish Pigmentation Screening Service
Accelerate hit identification with a whole-organism zebrafish platform that combines in vivo relevance, non-invasive imaging, and scalable throughput.
Request a consultationRapid, ethical, and cost-effective screening for depigmenting and melanin-regulating compounds
Cosmetic ingredient developers and pharmaceutical teams face a common challenge: cell-based assays lack whole-organism context, yet mammalian models are slow and costly for early-stage screening. Zebrafish embryos provide an ideal middle ground — optically transparent, easy to handle, and amenable to automated imaging.
Our high-throughput screening service leverages the zebrafish model to evaluate your compound libraries for pigmentation-modulating activity. Compounds are added to embryo medium, and melanin area is quantified via automated brightfield microscopy and image analysis. This approach yields hits with in vivo relevance, enabling you to prioritize candidates before advancing to mammalian studies.
We support a wide range of study designs, from single-concentration primary screens to multi-dose dose-response assessments. Each project is scoped collaboratively to match your assay requirements, compound numbers, and desired endpoints.
Why Zebrafish for Pigment Screening? Zebrafish share key pigmentation pathways with humans, including melanogenesis enzymes (tyrosinase, TYRP1/2) and melanosome transport. Their translucency allows direct, non-invasive quantification of melanin changes in live embryos.
Three advantages that set our platform apart for compound screening.
We accommodate 96- and 384-well plate formats, enabling evaluation of hundreds to thousands of compounds per campaign. Automated liquid handling and imaging ensure consistent, high-quality data across replicates.
By measuring pigment area in live zebrafish embryos, you capture bioavailability, metabolism, and off-target effects that cell-based assays miss. This in vivo context reduces false positives and improves translatability.
From assay development and miniaturization through pilot screening to full HTS and hit validation, we provide a seamless workflow. Our team also offers secondary dose-response analysis and statistical reporting tailored to your project.
A step-by-step description of the biological and technical basis.
Zebrafish embryos remain optically clear for the first several days post-fertilization, allowing direct visualization of melanin pigmentation without dissection or staining.
Test compounds are dissolved in embryo medium and added to individual wells. Embryos absorb compounds through the skin and gills, enabling systemic exposure assessment.
At the endpoint, embryos are imaged using brightfield microscopy with automated stage control. Multiple images per well capture the head and trunk regions where melanin is most abundant.
Custom image analysis algorithms segment melanin pixels from background and calculate the total pigmented area per embryo. Changes relative to vehicle control are reported as percent inhibition or enhancement.
Primary hits are defined by a user-specified activity threshold. Selected hits are then tested across a concentration series to generate EC50 or IC50 values and assess cytotoxicity.
Modeling a spectrum of pigmentation disorders and cosmetic needs.
Evaluate compounds to reduce hyperpigmentation in a pattern similar to facial melasma.
Test depigmenting agents against UV-induced age spots using a zebrafish UV model.
Screen compounds that modulate pigmentation following inflammatory stimuli.
Identify promoters of melanocyte regeneration and melanin synthesis for vitiligo therapy.
Assess efficacy and safety of natural extracts or synthetics for skin-lightening products.
Rapidly screen multiple leads for reducing genetically determined pigment spots.
Detect unwanted pigmentation side effects of pharmaceutical candidates early in development.
Explore pigment-regulating compounds as potential adjuvants in melanoma research.
A side-by-side comparison of key features for pigmentation screening.
| Feature | Zebrafish (Our Service) | Mouse Models | Cell-Based Assays | Organoids / 3D Skin |
|---|---|---|---|---|
| Throughput (compounds per run) | High (384-well format) | Low (≤ 20 per cohort) | Very high (1536-well) | Moderate (96-well) |
| Whole-organism context | Yes | Yes | No | Partial (skin only) |
| Ethical / regulatory burden | Low (embryos ≤ 5 dpf not regulated) | High (protocols, ethics approval) | None | Low (donor consent only) |
| Melanin quantification method | Non-invasive brightfield microscopy | Skin biopsy + histology or reflectance | Biochemical tyrosinase assay or melanin extraction | Histology or imaging |
| Relevance to human pigmentation | High (shared melanogenesis pathways) | High but different coat color genetics | Moderate (melanocytes only, no systemic effects) | High (human-derived skin) |
| Compound library size supported | Up to thousands per campaign | Tens | Hundreds of thousands | Hundreds |
From consultation to hit report in three streamlined stages.
We discuss your screening goals, compound library characteristics, and desired endpoints (e.g., melanin area, embryo viability). For novel assays, we perform miniaturization and optimization in 96- or 384-well plates, including vehicle tolerance and positive control testing.
Compounds are delivered at the specified concentration(s) to wells containing developmentally staged embryos. Plates are incubated at 28.5°C under controlled light cycles for a defined period (typically 48–72 hpf). Embryo survival is monitored daily.
At the endpoint, live embryos are imaged with an automated brightfield microscope. Images are analyzed using proprietary software to calculate melanin area per embryo. Data are normalized to vehicle controls, hits are flagged, and a comprehensive report is delivered.
Robust computational methods to quantify pigmentation and call hits.
Concrete use cases for our high-throughput zebrafish pigmentation screening.
Rapidly rank-order candidate natural extracts or synthetic whitening agents by in vivo efficacy. For example, screen a 100+ botanical library to identify tyrosinase inhibitors with minimal toxicity before progressing to patch tests.
Evaluate lead compounds targeting melanocortin 1 receptor (MC1R) or MITF signaling. Our platform provides dose-response data to optimize potency and selectivity in a whole-organism context.
Assess on-target versus off-target effects: compounds that reduce pigmentation may also affect embryo development. We include viability and morphological scoring alongside pigmentation readout.
Identify agents that stimulate melanocyte migration and melanin synthesis. Use our model to screen for compounds that rescue pigmentation in melanocyte-depleted embryos.
Indicative parameters per study. Exact scope is finalized during consultation.
| Project Type | Material Required | Amount | Turnaround |
|---|---|---|---|
| Primary Screen – Single Concentration | Compound library in DMSO or medium | 10–200 compounds | Scoped per project |
| Dose-Response Screen (IC50/EC50) | Hit compounds from primary screen | 5–20 compounds, 6–8 concentrations | Scoped per project |
| Mechanistic Study (Time Course) | Selected test compound(s) | 1–5 compounds, multiple time points | Scoped per project |
| Toxicity & Pigmentation Dual Readout | Compound(s) | Scoped per project | |
| Positive Control Validation | Reference compound (e.g., kojic acid, arbutin) | Single compound, 5–8 concentrations | Scoped per project |
Every project includes a comprehensive data package.
Common questions about our zebrafish pigmentation HTS service.
How many compounds can be screened in a single campaign?
We routinely run 96- and 384-well plates, allowing up to several hundred compounds per plate. The total throughput depends on the number of plates and replicates; we recommend discussing your library size during scoping to determine the optimal plate count and timeline.
What endpoints do you measure besides pigmentation?
We also record embryo viability, morphological abnormalities, and general health scores. These endpoints help differentiate specific depigmenting effects from non-specific toxicity. Optional endpoints like locomotor activity or reactive oxygen species can be added upon request.
How do you ensure the pigmentation readout is quantifiable and reproducible?
Imaging uses standardized brightfield illumination, autofocus, and stage positioning. Our image analysis pipeline applies field flat-field correction, consistent segmentation thresholds, and automated quality checks. Each plate includes vehicle and positive control wells to normalize batch effects.
Can you screen natural extracts or complex mixtures?
Yes, as long as the extract is soluble or can be suspended in embryo medium at the test concentration. We recommend pre-testing for embryo compatibility. For complex mixtures, we can run a pilot screen to assess baseline toxicity and pigmentation effects.
What is the typical project timeline?
Timelines depend on compound number, replicate requirements, and whether assay development is needed. A typical primary screen with 100 compounds in singlicate can be completed in timeline scoped per project after consultation after assay readiness. Please contact us for an estimate tailored to your project.
Is the zebrafish pigmentation pathway relevant to human skin?
Zebrafish share orthologous genes for tyrosinase, TYRP1, TYRP2, and melanosome transport proteins. Many whitening compounds active in zebrafish (e.g., kojic acid, niacinamide) show parallel effects in human melanocyte assays and clinical studies, supporting translational value.
Tell Us What Happened
Please contact us if you have questions about our company, our products, or general enquiries.
Please use the form.